Jon McIver, MD
Neurological Surgery · Saint Paul, MNNPI 1689653792
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,573 of the $2,459 with a category attached, or 64.0%. 14 manufacturers reported payments, led by Medtronic at 59.2% of the total. Reporting peaked in 2020 at $1,037 and has fallen 90.4% since, to $100 in 2025.
Across 36 payments — averaging $68.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- Spineology Inc.$267
- Nevro Corp.$169
- Johnson & Johnson$143
- Globus Medical$124
- Boston Scientific$56
- plus $244 from 8 others
What the payments were for
- Travel & lodging$88636%
- Food & beverage$1,57364%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 13 | $1,456 |
| Spineology Inc. | 3 | $267 |
| Nevro Corp. | 1 | $169 |
| Johnson & Johnson(2 entities) | 5 | $143 |
| Globus Medical | 1 | $124 |
| Boston Scientific | 2 | $56 |
| Arteriocyte Medical Systems, Inc. | 2 | $45 |
| Orthofix Medical, Inc. | 2 | $40 |
| Azurity Pharmaceuticals, Inc. | 2 | $40 |
| Lifenet Health | 1 | $33 |
| Stryker | 1 | $25 |
| Baxter Healthcare | 1 | $21 |
| Native Surgical, LLC | 1 | $20 |
| Solventum Corporation | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,459 in reported general payments places this provider in the 60th percentile of 140 neurological surgery providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 81 | $997 |
| Nortriptyline Hcl | 18 | $147 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 14 | $146 |
| Oxycodone Hcl | 15 | $127 |
| Cyclobenzaprine Hcl | 20 | $110 |
| Tramadol Hcl | 24 | $80 |
| Amitriptyline Hcl | 12 | $48 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Saint Paul
- Andrew GrandeSaint Paul$88K
- David MannSaint Paul$13K
- Justin CohenSaint Paul$5K
- Ramachandra TummalaSaint Paul$3K
- Asif MaknojiaSaint Paul$2K
- Kendall LeeRochester$2.3M
- Michael FinnEdina$1.4M
- Stanley SkinnerMinneapolis$445K
- Rohan LallEdina$227K
- Matthew DaviesDuluth$163K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.